A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to cellular therapies.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
S. 2689 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 2689 — 114th Congress: REGROW Act. Retrieved from https://www.govtrack.us/congress/bills/114/s2689
“S. 2689 — 114th Congress: REGROW Act.” www.GovTrack.us. 2016. January 16, 2017 <https://www.govtrack.us/congress/bills/114/s2689>
|title=S. 2689 (114th)
|accessdate=January 16, 2017
|author=114th Congress (2016)
|date=March 16, 2016
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.